Evidence map›Paper›PMID 36992809›Full record

ArticleFrontiers in endocrinology2023

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency.

Peng Tang, Jun Zhang, Song Peng, Yapeng Wang, Haoyang Li, Ze Wang, Yao Zhang, Yiqiang Huang, Jing Xu, Dianzheng Zhang and 4 more

Open access · goldFull text read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Short-Read NGS of a Long-RangeInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Peng TangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Jun ZhangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Song PengDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Yapeng WangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Haoyang LiFifteen Squadron Five Brigade, School of Basic Medical Science, Army Medical University, Chongqing, China.
Ze WangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Yao ZhangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Yiqiang HuangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Jing XuDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Dianzheng ZhangDepartment of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Qiuli LiuDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Luofu WangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Weihua LanDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Jun JiangDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Army Medical University · CNDaping Hospital · CNPhiladelphia College of Osteopathic Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: 21-hydroxylase deficiency (21OHD) is the most common cause of congenital adrenal hyperplasia (CAH). However, patients with 21OHD manifest various phenotypes due to a wide-spectrum residual enzyme activity of different CYP21A2 mutations. Methods: A total of 15 individuals from three unrelated families were included in this study. Target Capture-Based Deep Sequencing and Restriction Fragment Length Polymorphism was conducted on peripheral blood DNA of the three probands to identify potential mutations/deletions in CYP21A2; Sanger sequencing was conducted with the DNA from the family members of the probands. Results: Dramatically different phenotypes were seen in the three probands of CAH with different compound heterozygous mutations in CYP21A2. Proband 1 manifested simple virilizing with mutations of 30-kb deletion/c.[188A>T;518T>A], the latter is a novel double mutants classified as SV associated mutation. Although both probands carry the same compound mutations [293-13C>G]:[518T>A], gonadal dysfunction and giant bilateral adrenal myelolipoma were diagnosed for proband 2 and proband 3, respectively. Conclusion: Both gender and mutations contribute to the phenotypes, and patients with the same compound mutations and gender could present with different phenotypes. Genetic analysis could help the etiologic diagnosis, especially for atypical 21OHD patients.

Indexed as

Adrenal Hyperplasia, CongenitalGenetic Association StudiesGenotypeHumansSteroid 21-HydroxylaseCYP21A2 protein, humanSteroid 21-Hydroxylase21OHDcongenital adrenal hyperplasiaCYP21A2genotypephenotype

Identifiers

PMID36992809
PMCPMC10042299
OpenAlexW4324044613

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read13
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.